drugset / Trial / NCT03105193

Intravenous and Intraperitoneal Lignocaine for Perioperative Analgesia in Laparoscopic Colon Resections

NCT03105193 ↗

Phase 4 Completed 60 enrolled University of Auckland, New Zealand
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this study is to investigate the analgesic effects of intraperitoneal lignocaine (IPL) compared with intravenous lignocaine (IVL) after laparoscopic colon resections. We plan to run a 2 group randomized, double blind, clinical trial which will look into morphine consumption as the primary outcome. Group 1 (IV lignocaine)- IV bolus of lignocaine and a 3 day post operative IV lignocaine infusion. Intra peritoneal (IP) bolus of normal saline + 3 day post operative IP normal saline infusion Group 2 (IP lignocaine)- IV bolus of normal saline and a 3 day post operative IV normal saline infusion. IP bolus of lignocaine + 3 day post operative IP lignocaine infusion

Timeline

Start
2018-08-17
Primary completion
2019-12-01
Completion
2019-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified — Intravenous

Indications

No indication recorded.